NimishAMohileMD

Neurology • Rochester, NY

Neurooncology

Assistant Professor, Neurology, University of Rochester School of Medicine & Dentistry

Join to view full profile

Dr. Mohile is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mohile's full profile

Already have an account?

Office
601 Elmwood Ave
Rochester, NY 14642
Phone+1 585-275-5863

Fax+1 585-273-1051

Summary

Dr. Nimish Mohile is a neurologist in Rochester, NY and is affiliated with multiple hospitals in the area, including Highland Hospital and Strong Memorial Hospital of the University of Rochester. He received his medical degree from St. George's University School of Medicine and has been in practice 17 years. He specializes in neurooncology and is experienced in general neurology.

Education & Training

McGaw Medical Center of Northwestern UniversityResidency, Neurology, 2001 - 2004
Norwalk Hospital/Yale UniversityInternship, Internal Medicine, 2000 - 2001
St. George's University School of MedicineClass of 2000

Certifications & Licensure

NY State Medical License 2004 - 2026
IL State Medical License 2001 - 2005
American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012

Clinical Trials

Memantine for Recurrent Glioblastoma Start of enrollment: 2010 Nov 01
Terminated
Phase 2
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
Completed
Phase 2
Dose-Escalation Study of TPI 287 + Avastin Followed by Randomized Study of the Same Versus Avastin for Glioblastoma Start of enrollment: 2013 Aug 01
Suspended
Phase 1, Phase 2
Safety & Efficacy Study of TPI 287 + Avastin in Adults With Glioblastoma That Progressed Following Prior Avastin Therapy Start of enrollment: 2014 Jan 01
Terminated
Phase 2
A Study of Maprotiline in Combination With Tamoxifen and Temozolomide for Recurrent Glioblastoma Start of enrollment: 2022 Jun 01
Withdrawn
Phase 1
Roles: Contact, Principal Investigator
Pivotal, Randomized, Open-label Study of Optune® (Tumor Treating Fields) Concomitant With RT & TMZ for the Treatment of Newly Diagnosed GBM Start of enrollment: 2020 Dec 08
Active, not recruiting
Not Applicable
Roles: Contact
Join now to see all

Publications & Presentations

PubMed

23 citations
Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.
Jennifer S. Gewandter, Jenna Chaudari, Chinazom Ibegbu, Rachel A. Kitt, Jennifer Serventi
Supportive Care in Cancer. 2019-05-01
272 citations
Treatment for Brain Metastases: ASCO-SNO-ASTRO Guideline.
Michael A Vogelbaum, Paul D Brown, Hans Messersmith, Priscilla K Brastianos, Stuart Burri
Journal of Clinical Oncology. 2022-02-10
2 citations
Pilot trial testing the effects of exercise on chemotherapy-induced peripheral neurotoxicity (CIPN) and the interoceptive brain system.
Ian R Kleckner, Thushini Manuweera, Po-Ju Lin, Kaitlin H Chung, Amber S Kleckner
Research Square. 2024-03-13

Press Mentions

Glioma Signature Predicts Outcomes in GlioblastomaJune 1st, 2016
Glioma Signature Predicts Outcomes in GlioblastomaJune 1st, 2016